Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome–wide interaction study

Anja Rudolph(Institut für Qualität im Management (Germany)), Heli Nevanlinna(University of Helsinki), Hiltrud Brauch(German Cancer Research Center), Laura Baglietto, Thomas Brüning(Institute for Prevention and Occupational Medicine), Graham G. Giles(The University of Melbourne), Jonine D. Figueroa, Thérèse Truong(Université Paris-Sud), Anthony J. Swerdlow(Institute of Cancer Research), F. Ménégaux(Université Paris-Sud), Hugues Aschard(Harvard University), Pascal Guénel(Inserm), Mikael Eriksson(Herlev Hospital), Volker Harth(Universität Hamburg), Kamila Czene(Karolinska Institutet), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Jean Wang(Princess Margaret Cancer Centre), Sabine Behrens(German Cancer Research Center), Anna Marie Mulligan, Per Hall(Karolinska Institutet), Lars Beckmann(German Cancer Research Center), Celine M. Vachon(Leiden University Medical Center), Montserrat García‐Closas(Institute of Cancer Research), Melissa C. Southey(The University of Melbourne), Gianluca Severi(Inserm), Jianjun Liu(University of Kentucky), Alan Ashworth(Breast Cancer Research Foundation), Julia A Knight(University of Toronto), Irene L Andrulis(Mount Sinai Hospital), Keith Humpreys(Heidelberg University), Fergus J Couch(Mayo Clinic), Stephen J Chanock(National Institutes of Health), Douglas F. Easton(Heidelberg University), Emilie Cordina‐Duverger(Mayo Clinic), Hatef Darabi, Janet E. Olson(Mayo Clinic in Florida), Gord Glendon(University of Toronto), Sara Lindström(Harvard University), Rebecca Hein(Technical University of Munich), Dieter Flesch-Janys(Universität Hamburg), D. J. Hunter(Heidelberg University), Manjeet K. Bolla(University of Cambridge), Jolanta Lissowska, Kristen N. Stevens(University of Michigan), Minouk J. Schoemaker(Institute of Cancer Research)
Endocrine Related Cancer
September 30, 2013
Cited by 29


Related Papers